NO965244D0 - Farmasöytisk preparat inneholdende et hydrofobt aktivt stoff og et brusesystem, og fremgangsmåte til fremstilling derav - Google Patents
Farmasöytisk preparat inneholdende et hydrofobt aktivt stoff og et brusesystem, og fremgangsmåte til fremstilling deravInfo
- Publication number
- NO965244D0 NO965244D0 NO965244A NO965244A NO965244D0 NO 965244 D0 NO965244 D0 NO 965244D0 NO 965244 A NO965244 A NO 965244A NO 965244 A NO965244 A NO 965244A NO 965244 D0 NO965244 D0 NO 965244D0
- Authority
- NO
- Norway
- Prior art keywords
- hydrophobic active
- pct
- active substance
- preparation
- pharmaceutical composition
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title abstract 3
- 230000002209 hydrophobic effect Effects 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000004094 surface-active agent Substances 0.000 abstract 2
- 239000006185 dispersion Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 229920000136 polysorbate Polymers 0.000 abstract 1
- 229940068965 polysorbates Drugs 0.000 abstract 1
- 235000000346 sugar Nutrition 0.000 abstract 1
- 150000008163 sugars Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH01890/94A CH686865A5 (de) | 1994-06-15 | 1994-06-15 | Pharmazeutische Zubereitung mit einem hydrophoben Wirkstoff und einem Brausesystem, sowie Verfahren zur Herstellung der Zubereitung. |
| PCT/EP1995/001904 WO1995034284A1 (de) | 1994-06-15 | 1995-05-19 | Pharmazeutische zubereitung mit einem hydrophoben wirkstoff und einem brausesystem, sowie verfahren zur herstellung der zubereitung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO965244D0 true NO965244D0 (no) | 1996-12-09 |
| NO965244L NO965244L (no) | 1997-02-13 |
| NO314016B1 NO314016B1 (no) | 2003-01-20 |
Family
ID=4221002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19965244A NO314016B1 (no) | 1994-06-15 | 1996-12-09 | Farmasöytisk preparat inneholdende en hydrofob aktiv substans og et brusesystem, og fremgangsmåte til fremstilling derav |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5834019A (no) |
| EP (1) | EP0768868B1 (no) |
| JP (1) | JPH10501535A (no) |
| KR (1) | KR100367302B1 (no) |
| CN (1) | CN1149071C (no) |
| AT (1) | ATE204744T1 (no) |
| AU (1) | AU684966B2 (no) |
| BR (1) | BR9508002A (no) |
| CA (1) | CA2191302C (no) |
| CH (1) | CH686865A5 (no) |
| CO (1) | CO4410175A1 (no) |
| CZ (1) | CZ287807B6 (no) |
| DE (1) | DE59509566D1 (no) |
| ES (1) | ES2161901T3 (no) |
| HU (1) | HU221680B1 (no) |
| IL (1) | IL114144A (no) |
| MX (1) | MX9606391A (no) |
| MY (1) | MY113718A (no) |
| NO (1) | NO314016B1 (no) |
| NZ (1) | NZ288208A (no) |
| PE (1) | PE42295A1 (no) |
| PL (1) | PL180135B1 (no) |
| SK (1) | SK281262B6 (no) |
| TW (1) | TW457097B (no) |
| WO (1) | WO1995034284A1 (no) |
| ZA (1) | ZA954932B (no) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69713948D1 (de) * | 1996-04-23 | 2002-08-22 | Janssen Pharmaceutica Nv | Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid |
| EP0803251B1 (en) * | 1996-04-23 | 2002-07-17 | Janssen Pharmaceutica N.V. | Immediate release pH-independent solid dosage form of cisapride |
| AU7919398A (en) * | 1997-06-11 | 1998-12-30 | Janssen Pharmaceutica N.V. | Immediate release ph-independent solid dosage form of (+)- or (-)-cisapride |
| US6589555B2 (en) | 1999-12-29 | 2003-07-08 | Mahendra Pandya | Effervescent vitaceutical compositions and related methods |
| RU2164796C1 (ru) * | 2000-05-25 | 2001-04-10 | Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" | Противогистаминное средство и способ его получения |
| WO2002036077A2 (en) * | 2000-11-06 | 2002-05-10 | Andrx Pharmaceuticals, Inc. | Once a day antihistamine and decongestant formulation |
| EP1418945A2 (en) * | 2001-03-13 | 2004-05-19 | Angiotech Pharmaceuticals, Inc. | Micellar drug delivery vehicles and uses thereof |
| US20030157170A1 (en) * | 2001-03-13 | 2003-08-21 | Richard Liggins | Micellar drug delivery vehicles and precursors thereto and uses thereof |
| DK1392254T3 (da) * | 2001-04-20 | 2007-07-02 | Univ British Columbia | Micelle-lægemiddelindgivelsessystem for hydrofobe lægemidler |
| MXPA04003623A (es) * | 2001-10-19 | 2004-12-02 | Isotechnika Inc | Nuevas formulaciones analogas de ciclosporina. |
| US8092831B2 (en) * | 2002-11-08 | 2012-01-10 | Andrx Pharmaceuticals, Llc | Antihistamine and decongestant system |
| US20050069590A1 (en) * | 2003-09-30 | 2005-03-31 | Buehler Gail K. | Stable suspensions for medicinal dosages |
| US7491263B2 (en) | 2004-04-05 | 2009-02-17 | Technology Innovation, Llc | Storage assembly |
| CN100381123C (zh) * | 2005-01-12 | 2008-04-16 | 南京亿华药业有限公司 | 一种氯雷他定颗粒剂及其制法 |
| CN101897732B (zh) * | 2009-05-27 | 2013-01-30 | 北京因科瑞斯医药科技有限公司 | 一种中药泡腾片剂及其制备方法 |
| CN106236713B (zh) * | 2016-08-30 | 2018-11-09 | 林州中农颖泰生物肽有限公司 | 一种七清败毒泡腾颗粒及其制备方法 |
| CN107296800A (zh) * | 2017-06-01 | 2017-10-27 | 江苏黄河药业股份有限公司 | 一种氯雷他定泡腾片及其制备方法 |
| CN112741841A (zh) * | 2019-10-29 | 2021-05-04 | 湖北真奥医药研究院有限公司 | 三维钙自乳化泡腾剂组合物及其制剂的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3584522D1 (de) * | 1984-12-14 | 1991-11-28 | Gergely Gerhard | Teilchen aus einer hydrophoben oder schwerloeslichen substanz und verfahren zu ihrer hydrophilisierung. |
| GB8528195D0 (en) * | 1985-11-15 | 1985-12-18 | Boots Co Plc | Therapeutic compositions |
| GB9224021D0 (en) * | 1992-11-16 | 1993-01-06 | Boots Co Plc | Effervescent compositions |
| US5646131A (en) * | 1994-02-22 | 1997-07-08 | The Arab Company For Drug Industries And Medical Applicances (Acdima) | Method for solubilizing drugs using cyclodextrins and carboxylic acids |
| GB9405304D0 (en) * | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
-
1994
- 1994-06-15 CH CH01890/94A patent/CH686865A5/de not_active IP Right Cessation
-
1995
- 1995-05-19 AU AU27497/95A patent/AU684966B2/en not_active Ceased
- 1995-05-19 ES ES95922463T patent/ES2161901T3/es not_active Expired - Lifetime
- 1995-05-19 CN CNB95193578XA patent/CN1149071C/zh not_active Expired - Fee Related
- 1995-05-19 EP EP95922463A patent/EP0768868B1/de not_active Expired - Lifetime
- 1995-05-19 WO PCT/EP1995/001904 patent/WO1995034284A1/de not_active Ceased
- 1995-05-19 CZ CZ19963672A patent/CZ287807B6/cs not_active IP Right Cessation
- 1995-05-19 DE DE59509566T patent/DE59509566D1/de not_active Expired - Lifetime
- 1995-05-19 AT AT95922463T patent/ATE204744T1/de active
- 1995-05-19 NZ NZ288208A patent/NZ288208A/en unknown
- 1995-05-19 BR BR9508002-3A patent/BR9508002A/pt active Search and Examination
- 1995-05-19 SK SK1593-96A patent/SK281262B6/sk unknown
- 1995-05-19 HU HU9603452A patent/HU221680B1/hu not_active IP Right Cessation
- 1995-05-19 MX MX9606391A patent/MX9606391A/es not_active IP Right Cessation
- 1995-05-19 JP JP8501534A patent/JPH10501535A/ja not_active Ceased
- 1995-05-19 KR KR1019960706945A patent/KR100367302B1/ko not_active Expired - Fee Related
- 1995-05-19 PL PL95317856A patent/PL180135B1/pl unknown
- 1995-05-19 CA CA2191302A patent/CA2191302C/en not_active Expired - Fee Related
- 1995-05-19 US US08/737,580 patent/US5834019A/en not_active Expired - Lifetime
- 1995-06-14 CO CO95026284A patent/CO4410175A1/es unknown
- 1995-06-14 IL IL11414495A patent/IL114144A/xx not_active IP Right Cessation
- 1995-06-14 PE PE1995271312A patent/PE42295A1/es not_active Application Discontinuation
- 1995-06-14 ZA ZA954932A patent/ZA954932B/xx unknown
- 1995-06-15 MY MYPI95001623A patent/MY113718A/en unknown
- 1995-06-15 TW TW084106115A patent/TW457097B/zh not_active IP Right Cessation
-
1996
- 1996-12-09 NO NO19965244A patent/NO314016B1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO965244D0 (no) | Farmasöytisk preparat inneholdende et hydrofobt aktivt stoff og et brusesystem, og fremgangsmåte til fremstilling derav | |
| ATE183495T1 (de) | 6-dimethylaminomethyl-1-phenyl-cyclo- hexanverbindungen als pharmazeutische wirkstoffe | |
| ATE188961T1 (de) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1- olverbindungen als pharmazeutische wirkstoffe | |
| DK0993830T3 (da) | Nye stabiliserede galeniske formuleringer indeholdende en syrelabil benzimidazolforbindselse og fremgangsmåde til fremstilling heraf | |
| DK0760649T3 (da) | Præparater af fluticason-propionat | |
| BR9503386A (pt) | Formulaçao farmacêutica comprimido dispersivel e processo para a fabricaçao de comprimidos dispersíveis contendo cloridrato de fluoxetina | |
| AU5651696A (en) | Substituted 1-phenyl-3-pyrazolecarboxamides active on nurotensin receptors, their preparation and pharmaceutical compositions containing them | |
| RU94045129A (ru) | Состав для похудения для местного применения, содержащий два типа липосом, и способ уменьшения и/или устранения полноты и/или избыточного веса | |
| FR2771291B1 (fr) | Spheroides, procede de preparation et compositions pharmaceutiques | |
| GEP20002211B (en) | Taxoids, Preparation Thereof, Pharmaceutical Compositions Containing Same | |
| FR2707882B1 (fr) | Nouveaux kits thérapeutiques anti-médiateurs protéiques, procédé de préparation et compositions pharmaceutiques les renfermant. | |
| ES2102475T3 (es) | Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| ES2178154T3 (es) | Proceso de preparacion de formas solidas de dosificacion farmaceutica. | |
| NO20005332L (no) | 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding | |
| MA23663A1 (fr) | Procede de preparation de formulations pharmaceutiques | |
| SE8302580L (sv) | Substituerade iminoderivat av dihydrobensopyran och dihydrobensotiopyran och forfarande for deras framstellning | |
| BR9508021A (pt) | Composição farmacêutica para o tratamento de distúrbios esquizofrênicos, uso de um agente imunossupressor, e, processo de tratamento de um paciente esquizofrênico | |
| HRP940315B1 (en) | Process for the preparation of pharmaceutical compositions containinbg active ingredient | |
| NO980384D0 (no) | Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler | |
| AU7623496A (en) | Stable mixtures of incompatible active ingredients for plant protection | |
| ES2162986T3 (es) | Derivados de mercapto-alcanoil-dipeptidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| DE69620928D1 (de) | Physiologisch aktive Substanzen PF1092A, PF1092B, und PF1092C, Verfahren zu deren Herstellung, sowie diese als aktive Bestandteile enthaltende empfängnisverhütende Mittel und Antikrebsmittel | |
| EE03658B1 (et) | Pestitsiidpreparaadid ja protsess nende valmistamiseks | |
| AU5145396A (en) | Mechanically stable solid formulations of active substances | |
| MX9305997A (es) | 6-heterociclic-4-amino-1, 2, 2a, 3, 4, 5-hexahidrobenz[cd]indoles yprocedimiento para su preparacion. |